The development of COVID-19 vaccines is moving at an unprecedented rate. Whether it takes weeks or even years for a vaccine to be approved, initial supplies will be limited. This
All posts in Public Health
Reminder : European Scientist is not a peer-reviewed scientific journal. The opinion below is only up to its authors. Abstract Great public organisations like the WHO tend to lack proper
In a report released on 3 September, a group of experts from ten countries conclude that germline editing of human embryos is still too risky due to unresolved scientific and
Asphalt may be a significant, yet overlooked, source of air pollution in urban areas. In a new paper published on 2 September in Science Advances, scientists reveal that common road
Since the novel coronavirus (SARS-Cov-2) was declared a pandemic last March, there have been mixed opinions about whether or not face masks can effectively slow the spread of the virus.
On August 24, Hong Kong scientists confirmed what appears to be “the first instance of human reinfection” with the novel coronavirus (SARS-Cov-2). The 33-year-old man was reinfected for a second
A new spate of studies has hinted at the possibility of “strong, lasting immunity” to the novel coronavirus (SARS-Cov-2) even after a mild COVID-19 infection. Powerful responses were observed in
From snowfall on remote mountaintops from the Arctic to the European Alps to the deepest depths of the ocean, microplastics have been documented in virtually every corner of the world.
On Tuesday August 11, Russia became the first country to approve a vaccine against the novel coronavirus (Sars-Cov-2). The news was announced by Russian President Vladimir Putin that the vaccine, called
People who test positive for the novel coronavirus (SARS-CoV-2) but never develop symptoms may carry as much of the virus in their nose, throat, and lungs – and for nearly